JP Morgan analyst updates estimates for Agilon Health, Inc. based on Q4 results and management’s outlook for recovery and growth in 2025-2027.
Latest Ratings for AGL
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 2021 | Deutsche Bank | Maintains | Buy | |
| Nov 2021 | SVB Leerink | Maintains | Outperform | |
| Oct 2021 | Jefferies | Initiates Coverage On | Buy |
